{"id":"W3090469545","doi":"10.1200/jco.20.00995","title":"Five-Year Outcomes With Nivolumab in Patients With Wild-Type <i>BRAF</i> Advanced Melanoma","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":227,"is_retracted":false,"has_abstract":true,"ca_institutions":"Royal Victoria Hospital; McGill University; University of British Columbia; BC Cancer Agency","funders":"Ono Pharmaceutical; Bristol-Myers Squibb","keywords":"Medicine; Nivolumab; Melanoma; Oncology; Internal medicine; Metastatic melanoma; Ipilimumab; Cancer research; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001409882,0.0003554727,0.0007294021,0.0001645001,0.0002470215,0.0004645406,0.0002287925,0.0005426673,0.0007359982],"category_scores_gemma":[0.000708806,0.00009167093,0.0009248088,0.0001409218,0.0002857028,0.0003004181,0.0001651068,0.0007846368,0.0001197038],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000476225,"about_ca_system_score_gemma":0.0003975783,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005761162,"about_ca_topic_score_gemma":0.001429555,"domain_scores_codex":[0.9997154,0.0001363124,0.00001869798,0.00004220943,0.00003313352,0.0000542411],"domain_scores_gemma":[0.9995599,0.0000748393,0.0001375547,0.00002147272,0.00002634359,0.0001798885],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5781552,0.01094673,0.1501248,0.0009763404,0.002908408,0.0004269033,0.0002080607,0.009112482,0.02355937,0.0003012103,0.004700197,0.2185804],"study_design_scores_gemma":[0.1216887,0.5810955,0.2769516,0.0002224335,0.002337067,0.0007627003,0.0001064339,0.004900011,0.005323123,0.0004013269,0.006154058,0.00005693356],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944724,0.004008486,0.0001747128,0.0001566612,0.00007009682,0.0001093857,0.0002178317,0.00001784773,0.0007726076],"genre_scores_gemma":[0.9979022,0.0007426638,0.000155176,0.0002988453,0.00008555498,0.0000750199,0.00041646,0.00000230773,0.0003219154],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001409882,"threshold_uncertainty_score":0.007456303,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02934943225884844,"score_gpt":0.3323646425640745,"score_spread":0.303015210305226,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}